CIK 0002023658
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Bicara Therapeutics Inc.
Sign in to watch- Ticker
- BCAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-468-4219
- Business address
- 116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $400,716
- in 1 filing, $401K under 10b5-1 plans
Net −$400,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-15 | Cohlhepp Ryan President and COO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −8,000 | 109,334 | ||
| 2026-03-16 | Cohlhepp Ryan President and COO | Exercise or conversion 10b5-1 | +8,000 | $3.79 | $30K | 213,141 |
| 2026-03-16 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −8,000 | $19.66 | $157K | 205,141 |
| 2026-03-16 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −4,500 | $19.66 | $88K | 200,641 |
| 2026-03-16 | Cohlhepp Ryan President and COO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −8,000 | 117,334 | ||
| 2026-03-03 | Cohlhepp Ryan President and COO | Exercise or conversion 10b5-1 | +12,892 | $3.79 | $49K | 222,533 |
| 2026-03-03 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −12,892 | $18.16 | $234K | 209,641 |
| 2026-03-03 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −4,500 | $18.16 | $82K | 205,141 |
| 2026-03-03 | Cohlhepp Ryan President and COO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −12,892 | 125,334 | ||
| 2026-02-25 | Cohlhepp Ryan President and COO | Exercise or conversion 10b5-1 | +3,108 | $3.79 | $12K | 213,272 |
| 2026-02-25 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −3,108 | $18.04 | $56K | 210,164 |
| 2026-02-25 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −523 | $18.04 | $9K | 209,641 |
| 2026-02-25 | Cohlhepp Ryan President and COO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −3,108 | 138,226 | ||
| 2026-02-02 | Cohlhepp Ryan President and COO | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2026-01-22 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −3,828 | $18.10 | $69K | 210,164 |
| 2026-01-15 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −149 | $18.02 | $3K | 213,992 |
| 2025-12-26 | Cohlhepp Ryan President and COO | Exercise or conversion | +25,000 | $4.44 | $111K | 214,141 |
| 2025-12-26 | Cohlhepp Ryan President and COO | Exercise or conversion · Stock Option (Right to Buy) | −25,000 | 39,909 | ||
| 2025-12-15 | Cohlhepp Ryan President and COO | Exercise or conversion 10b5-1 | +8,000 | $3.79 | $30K | 201,641 |
| 2025-12-15 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −8,000 | $18.68 | $149K | 193,641 |
Page 2 of 3 · 58 trades